The COVID-19 Therapeutics Accelerator is funding clinical trials that will answer whether the anti-malarial drugs hydroxychloroquine and chloroquine can be used to prevent the spread of COVID-19.
A vaccine for COVID-19 which uses cutting-edge RNA technology has entered phase 1 clinical trials. If successful, it could revolutionise the future of vaccine development.
Wellcome is supporting a step-change in COVID-19 testing by the UK government. Partners include the NHS, Public Health England, diagnostics companies Thermo Fisher Scientific, QIAGEN and Randox, UK universities, Boots, Royal Mail and Amazon.
Now is not the time to make cautious investments: now is the time for courageous action to tackle COVID-19.
At Heart n Soul at The Hub, we believe that anybody can contribute to research, and we’ve tried to create an environment to enable them to do so.
Following careful consideration of the rapidly changing COVID-19 pandemic, we’ve decided that the Wellcome Trust and Wellcome Collection buildings will begin a staggered closure to staff and visitors, and then remain closed until further notice.
Wellcome joins the Bill & Melinda Gates Foundation and Mastercard in launching a new initiative to speed the development of and access to therapies for COVID-19.
Getting public engagement funding from Wellcome has changed. We’ve shifted our approach from open-ended funding schemes to targeted investments that have specific aims.
Ricardo Henriques, Group Leader at UCL, looks at how lab leaders can create open and safe spaces for people to discuss any issues in research culture.